- Business Wire•14 hours agoFDA Expands Indication for REVLIMID® (lenalidomide) as a Maintenance Treatment for Patients with Multiple Myeloma Following Autologous Hematopoietic Stem Cell Transplant (auto-HSCT)
Celgene Corporation today announced that the U.S. Food and Drug Administration has expanded the existing indication for REVLIMID 10 mg capsules to include use for patients with multiple myeloma as maintenance therapy following autologous hematopoietic stem cell transplant .
- Zacks•23 hours ago
While Alexion (ALXN) reported a mixed quarter, Celgene provided promising data on a pipeline candidate.
- Motley Fool•yesterday
NVIDIA is delivering fantastic growth right now, and investors have seen huge gains. But there's risk that growth could stagnate. Three Foolish contributors offer up stocks you may want to consider buying instead.
CELG : Summary for Celgene Corporation - Yahoo Finance
Celgene Corporation (CELG)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||119.38 x 1000|
|Ask||120.47 x 300|
|Day's Range||118.84 - 120.50|
|52 Week Range||94.39 - 127.00|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||47.90|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|